Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
Rangering i aksjer
#4603
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Aksjekurs
$3.28
Markedsverdi
$3.32B
Endring (1 dag)
4.19%
Endring (1 år)
-10.41%
Land
CN
Handel Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Kategori
Healthcare
P/B-forhold for Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
P/B-forhold per October 2026 TTM: 2.55
Ifølge Jiangsu Nhwa Pharmaceutical Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 2.55. Ved slutten av 2023 hadde selskapet et P/B-forhold på 4.30.
P/B-historikk for Jiangsu Nhwa Pharmaceutical Co., Ltd. fra 2005 til 2026
P/B-forhold ved hvert års slutt
| År | P/B-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 2.55 | -24.63% |
| 2024 | 3.38 | -21.41% |
| 2023 | 4.30 | -2.38% |
| 2022 | 4.40 | 37.29% |
| 2021 | 3.20 | -18.27% |
| 2020 | 3.92 | 20.59% |
| 2019 | 3.25 | 9.26% |
| 2018 | 2.98 | -47.37% |
| 2017 | 5.65 | -10.10% |
| 2016 | 6.29 | -18.49% |
| 2015 | 7.72 | -17.46% |
| 2014 | 9.35 | -15.16% |
| 2013 | 11.02 | 47.24% |
| 2012 | 7.48 | 30.38% |
| 2011 | 5.74 | -33.54% |
| 2010 | 8.64 | 39.42% |
| 2009 | 6.19 | 73.28% |
| 2008 | 3.58 | -72.45% |
| 2007 | 12.98 | 12.26% |
| 2006 | 11.56 | 24.47% |
| 2005 | 9.29 | 0.00% |
P/B-forhold for lignende selskaper eller konkurrenter
| Selskap | P/B-forhold | Forskjell i P/B-forhold | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 97.87% |
IN
|
